Persistence Market Research

Beauty Devices Market - Global Study on Clinical Trial Management
System - Asia to Witness Highest Growth by 2019
Persistence Market Research
Global Clinical Trial Management System

Market Will Reach $1,848.5 million in 2019:

Persistence Market Research Released New Market Report Global Market Study on Clinical Trial
Management System: Asia to Witness Highest Growth by 2019 the global clinical trial
management system market was valued at USD 844.0 million in 2013 and is expected to grow
at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in
2019.
Browse the full Global Market Study on Clinical Trial Management System: Asia to Witness
Highest Growth by 2019 report at http://www.persistencemarketresearch.com/marketresearch/clinical-trial-management-system-market.asp
Clinical trial is a medical research study performed on humans to check the safety and
efficacy of drugs, devices and therapeutic products before they are finally launched in the
market. Globally, the CTMS market is witnessing significant growth due to increasing R&D
investment in pharmaceutical, life science and clinical research industries. It empowers
organizations and research centers to enhance productivity and effectiveness of clinical
trials by advancing and managing clinical trials. Integration of CTMS with hospital
information system (HIS) provides more accurate and time saving documentation is also
driving growth for the CTMS market. Additionally, increasing prevalence of diseases is
supporting clinical trials in different regions, and increased clinical research outsourcing is
playing a major role in the growth of the CTMS market. Increasing regulatory requirements in
many countries has resulted in increased complexity for clinical trial protocols. Presence of
various end users such as pharmaceuticals, clinical research organizations (CRO) and
healthcare providers has increased the acceptance of CTMS. The global CTMS market was
estimated to be USD 844 million in 2013. It is likely to grow at a CAGR of 14% during 2013 to
2019 to reach USD 1,848.5 million in 2019.
North America is a traditional clinical trial region. Due to regulatory and legal considerations
and the clinical trial market has shifted from North America to developing countries such as
India and China. Clinical trials in the U.S. have been funded and sponsored by National
Institute of Health (NIH), other government agencies, academic groups, voluntary health
organizations and industry.
In Europe, countries in Central and Eastern Europe provide abundant chance to life science
companies for clinical development. Due to governmental support and funding for
biomedical sciences, Germany has become a preferred location for clinical trials.
However, Asia is the fastest growing region in the clinical trial management system market..
Improved industry regulatory laws and patent expiration laws in various countries including
Japan, China and India, have led to the expansion of the clinical trials market in Asia. Asia
has lower cost of conducting clinical trials compared to Europe or the U.S.

Some of the major players in the CTMS market are Oracle Corporation, Bio-Optronics,
MedNet Solutions, PAREXEL International Corporation, Medidata Solutions and BioClinica
The clinical trial management system market is segmented as follows:
Clinical Trial Management System Market, By Delivery Mode
Cloud based clinical trial management system
Web based clinical trial management system
On-premise clinical trial management system
Clinical Trial Management System Market, By Type

Enterprise based clinical trial management system
Site based clinical trial management system
Clinical Trial Management System Market, By End user

Pharmaceuticals
Clinical Research Organizations
Healthcare providers
Clinical Trial Management System Market, By Components

Software
Hardware
Services
Clinical Trial Management System Market, by Geography

North America
U.S.
Europe
Germany
France
U.K.

Russia
Poland
Asia
China
South Korea
Taiwan
India
Rest of the World (RoW)
Market History:
Clinical trial management system (CTMS) is a software solution for proper management, storage and
analysis of drugs associated clinical data. Globally, the microfluidic device market is witnessing significant
growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing
demand. New trends in healthcare, such as health care at home, supports point of care testing (POCT) as
the most efficient and effective delivery of healthcare.
Additionally, the microfluidic technique has evolved into a new classification of research areas, targeting
integration of laboratory protocols into miniaturized devices called lab on chip. Miniaturization reduces the
cost for screening compounds in pharmaceutical companies for cell biology problems. Microfluidic
devices offer various advantages for genomics including improved test speed, reduced reagent
consumption and efficacy. Presence of various end users such as pharmaceuticals, clinical research
organizations (CRO) and healthcare providers has increased the acceptance of CTMS. The CTMS
market was estimated to be USD 844 million in 2013. It is likely to grow at a CAGR of 14% during 2013 to
2019 to reach USD 1,848.5 million in 2019.
North America has the largest market share in the global CTMS market. Web based CTMS is the largest
mode of delivery and pharmaceutical industry is the largest end user of CTMS. In terms of growth, Asia is
the fastest growing region, cloud based CTMS is the fastest growing mode of delivery and CROs are the
fastest growing end users of CTMS.

North American market for CTMS was estimated at USD 514.4 million in 2013 and is expected to reach
USD 1,107.5 million in 2019, growing at a CAGR of 13.6% from 2013 to 2019.
Web based CTMS was estimated at USD 603.4 million in 2013 and is expected to reach USD 1,392.1
million in 2019, growing at a CAGR of 15% from 2013 to 2019.
Software segment was estimated at USD 585 million in 2013 and is expected to reach USD 1,274.2
million in 2019, growing at a CAGR of 13.9% from 2013 to 2019.
Table of Content
Chapter 1 Preface 12
1.1 Report Description 12
1.2 Research Methodology 13

1.3 Assumptions 13
Chapter 2 Market Synopsis 14
Chapter 3 Porter Five Forces Analysis 16

3.1 Bargaining power of suppliers 16
3.2 Bargaining power of buyers 16
3.3 Threat of new entrants 17
3.4 Threat of substitutes 17
3.5 Intensity of rivalry 17
Chapter 4 Industry Overview 18

4.1 Market Definition 18
4.2 Market Drivers 20
4.2.1 Increasing research and development (R&D) investment in the pharmaceutical
industry 20
4.2.2 Increasing prevalence of disease is supporting importance of clinical trials in different
regions of the world 22

4.2.3 Assimilation of clinical trial management systems with Hospital Information System
(HIS) 22
4.2.4 Increased clinical research outsourcing and implementation of clinical trials by contract
research organizations 23
4.3 Impact Analysis of Market Drivers 24
4.4 Market Restraints 24
4.4.1 Longer approval time for clinical trials 24
4.4.2 Strict regulations to enrol patients for clinical trials 25
4.5 Impact Analysis of Market Restraints 26
4.6 Market Trends 26
4.6.1 Rising number of collaborations and partnerships 26
4.6.2 Increasing number of mergers and acquisitions 27
Chapter 5 Global Market Size and Forecast 29
Chapter 6 Market Size and Forecast by Mode of Delivery 31

6.1 Cloud based clinical trial management system 31
6.2 Web based clinical trial management system 32

6.3 On-premise clinical trial management system 32
Chapter 7 Market Size and Forecast by End User 34

7.1 Pharmaceuticals 34
7.2 Clinical Research Organizations (CROs) 34
7.3 Healthcare Providers 35
Chapter 8 Market Size and Forecast by Type 37

8.1 Enterprise based clinical trial management system 37
8.2 Site based clinical trial management system 37
Chapter 9 Market Size and Forecast by Components 39

9.1 Software 39
9.2 Hardware 40
9.3 Services 40
Chapter 10 Market Size and Forecast by Geography 42

10.1 North America 42

10.1.1 The U.S. 49
10.2 Europe 53
10.2.1 Germany 61
10.2.2 France 65
10.2.3 Poland 68
10.3 Asia 71
10.3.1 South Korea 79
10.3.2 China 82
10.4 Rest of the World 86
Chapter 11 Competitive Scenario 87

11.1 Competitive Benchmarking 87
Chapter 12 Company Profiles 89

12.1 Oracle Corporation 89
12.1.1 Company Overview 89
12.1.2 Products and Services 90

12.1.3 Financial Performance 90
12.1.4 Recent Developments 91
12.2 Merge Healthcare Incorporated 92
12.3 Medidata Solutions Inc. 95
12.4 PAREXEL International Corporation 98
10

12.5 BioClinica 100
12.6 MedNet Solutions, Inc. 103
12.7 Bio-Optronics, Inc. 105
11

12.8 DSG, Inc. 107
12.9 eClinForce, Inc. 108
12.10 Forte Research Systems, Inc. 109
12

List of Tables
TABLE 1 Market Snapshot: CTMS market (2013 & 2019) 14
TABLE 2 R&D investment in pharmaceutical industry, by country (USD million) in 2010 and
2011 21
TABLE 3 Globally rising prevalence of diabetics, by number of cases (million, 2010 and 2030)
22
TABLE 4 Drivers for CTMS market: Impact analysis 24
TABLE 5 Estimated average timelines for clinical trial approval in various countries 25
TABLE 6 Restraints for CTMS market: Impact analysis 26
TABLE 7 Major collaborations and partnerships by CTMS companies (2011- February 2014) 27
TABLE 8 Some of the major mergers and acquisitions in CTMS market (2011-Februrary 2014)
28
TABLE 9 Global clinical trial management system market size, by region 2009-2012 (USD
million) 29
TABLE 10 Global clinical trial management system market size, by region 2013-2019 (USD
million) 30
TABLE 11 Global clinical trial management system market size, by mode of delivery 2009-2012
(USD million) 32
TABLE 12 Global clinical trial management system market size, by mode of delivery 2013-2019
(USD million) 33
13

TABLE 13 Global clinical trial management system market size, by end user 2009-2012 (USD
million) 35
TABLE 14 Global clinical trial management system market size, by end user 2013-2019 (USD
million) 36
TABLE 15 Global clinical trial management system market size, by type 2009-2012 (USD
million) 38
TABLE 16 Global clinical trial management system market size, by type 2013-2019 (USD
million) 38
TABLE 17 Global clinical trial management system market size, by component 2009-2012 (USD
million) 40
TABLE 18 Global clinical trial management system market size, by component 2013-2019 (USD
million) 41
TABLE 19 The North American clinical trial management market size, by segment 2009-2012
(USD million) 43
TABLE 20 The North American clinical trial management market size, by segment 2013-2019
(USD million) 43
TABLE 21 The North American clinical trial management system market size, by mode of
delivery 2009-2012 (USD million) 44
TABLE 22 The North American clinical trial management system market size, by mode of
delivery 2013-2019 (USD million) 45
14

TABLE 23 The North American clinical trial management system market size, by end user 20092012 (USD million) 46
TABLE 24 The North American clinical trial management system market size, by end user 20132019 (USD million) 46
TABLE 25 The North American clinical trial management system market size, by type 20092012 (USD million) 47
TABLE 26 The North American clinical trial management system market size, by type 20132019 (USD million) 48
TABLE 27 The North American clinical trial management system market size, by component
2009-2012 (USD million) 49
TABLE 28 The North American clinical trial management system market size, by component
2013-2019 (USD million) 49
TABLE 29 The U.S. clinical trial management system market size, by mode of delivery 20092012 (USD million) 50
TABLE 30 The U.S. clinical trial management system market size, by mode of delivery 20132019 (USD million) 51
TABLE 31 The U.S. clinical trial management system market size, by end user 2009-2012 (USD
million) 52
TABLE 32 The U.S. clinical trial management system market size, by end user 2013-2019 (USD
million) 52
TABLE 33 The European clinical trial management market size, by segment 2009-2012 (USD
million) 54
15

TABLE 34 The European clinical trial management market size, by segment 2013-2019 (USD
million) 55
TABLE 35 The European clinical trial management system market size, by mode of delivery
2009-2012 (USD million) 56
TABLE 36 The European clinical trial management system market size, by mode of delivery
2013-2019 (USD million) 57
TABLE 37 The European clinical trial management system market size, by end user 2009-2012
(USD million) 58
TABLE 38 The European clinical trial management system market size, by end user 2013-2019
(USD million) 58
TABLE 39 The European clinical trial management system market size, by type 2009-2012
(USD million) 59
TABLE 40 The European clinical trial management system market size, by type 2013-2019
(USD million) 60
TABLE 41 The European clinical trial management system market size, by component 20092012 (USD million) 61
TABLE 42 The European clinical trial management system market size, by component 20132019 (USD million) 61
TABLE 43 The German clinical trial management system market size, by mode of delivery 20092012 (USD million) 62
16

TABLE 44 The German clinical trial management system market size, by mode of delivery 20132019 (USD million) 63
TABLE 45 The German clinical trial management system market size, by end user 2009-2012
(USD million) 64
TABLE 46 The German clinical trial management system market size, by end user 2013-2019
(USD million) 64
TABLE 47 The French clinical trial management system market size, by mode of delivery 20092012 (USD million) 65
TABLE 48 The French clinical trial management system market size, by mode of delivery 20132019 (USD million) 66
TABLE 49 The French clinical trial management system market size, by end user 2009-2012
(USD million) 67
TABLE 50 The French clinical trial management system market size, by end user 2013-2019
(USD million) 67
TABLE 51 Poland clinical trial management system market size, by mode of delivery 2009-2012
(USD million) 68
TABLE 52 Poland clinical trial management system market size, by mode of delivery 2013-2019
(USD million) 69
TABLE 53 Poland clinical trial management system market size, by end user 2009-2012 (USD
million) 70
TABLE 54 Poland clinical trial management system market size, by end user 2013-2019 (USD
million) 70
17

TABLE 55 The Asian clinical trial management market size, by segment 2009-2012 (USD
million) 72
TABLE 56 The Asian clinical trial management market size, by segment 2013-2019 (USD
million) 73
TABLE 57 The Asian clinical trial management system market size, by mode of delivery 20092012 (USD million) 74
TABLE 58 The Asian clinical trial management system market size, by mode of delivery 20132019 (USD million) 74
TABLE 59 The Asian clinical trial management system market size, by end user 2009-2012
(USD million) 75
TABLE 60 The Asian clinical trial management system market size, by end user 2013-2019
(USD million) 76
TABLE 61 The Asian clinical trial management system market size, by type 2009-2012 (USD
million) 77
TABLE 62 The Asian clinical trial management system market size, by type 2013-2019 (USD
million) 77
TABLE 63 The Asian clinical trial management system market size, by component 2009-2012
(USD million) 78
TABLE 64 The Asian clinical trial management system market size, by component 2013-2019
(USD million) 79
18

TABLE 65 The South Korean clinical trial management system market size, by mode of delivery
2009-2012 (USD million) 80
TABLE 66 The South Korean clinical trial management system market size, by mode of delivery
2013-2019 (USD million) 81
TABLE 67 The South Korean clinical trial management system market size, by end user 20092012 (USD million) 82
TABLE 68 The South Korean clinical trial management system market size, by end user 20132019 (USD million) 82
TABLE 69 The Chinese clinical trial management system market size, by mode of delivery
2009-2012 (USD million) 83
TABLE 70 The Chinese clinical trial management system market size, by mode of delivery
2013-2019 (USD million) 84
TABLE 71 The Chinese clinical trial management system market size, by end user 2009-2012
(USD million) 85
TABLE 72 The Chinese clinical trial management system market size, by end user 2013-2019
(USD million) 85
TABLE 73 Some of the Oracle Corporation categories and products 90
TABLE 74 Some of the Merge Healthcare categories and products 93
TABLE 75 Some of the Medidata Solutions products and applications 95
TABLE 76 Some of the PAREXEL International Corporation categories, products and services
98
19

TABLE 77 Some of the BioClinica categories and products 100

TABLE 78 Some of the MedNet Solutions categories and products 103
TABLE 79 Some of the Bio-Optronics products and application 105
TABLE 80 Some of the DSG products and application 107
TABLE 81 Some of the eClinForce products 108
TABLE 82 Some of the Forte Research Systems products and application 109
List of Figures
FIG. 1 CTMS Market: Porters Five Force Analysis 16
FIG. 2 Applications of clinical trial management system 19
FIG. 3 Process of CTMS 20
FIG. 4 Global clinical trial management system market, by region 2013E (% share) 29
FIG. 5 Global clinical trial management system market, by mode of delivery 2013E (% share) 31
FIG. 6 Global clinical trial management system market, by end user 2013E (% share) 34
FIG. 7 Global clinical trial management system market, by type 2013E (% share) 37
FIG. 8 Global clinical trial management system market, by components 2013E (% share) 39
20

FIG. 9 The North American clinical trial management system market, by country 2013E (%
share) 42
FIG. 10 The North American clinical trial management system market, by mode of delivery
2013E (% share) 44
FIG. 11 The North American clinical trial management system market, by end user 2013E (%
share) 45
FIG. 12 The North American clinical trial management system market, by type 2013E (% share)
47
FIG. 13 The North American clinical trial management system market, by component 2013E (%
share) 48
FIG. 14 The U.S. clinical trial management system market, by mode of delivery 2013E (%
share) 50
FIG. 15 The U.S. clinical trial management system market, by end user 2013E (% share) 51
FIG. 16 The European clinical trial management system market, by country 2013E (% share) 54
FIG. 17 The European clinical trial management system market, by mode of delivery 2013E (%
share) 56
FIG. 18 The European clinical trial management system market, by end user 2013E (% share)
57
FIG. 19 The European clinical trial management system market, by type 2013E (% share) 59
FIG. 20 The European clinical trial management system market, by component 2013E (%
share) 60
21

FIG. 21 The German clinical trial management system market, by mode of delivery 2013E (%
share) 62
FIG. 22 The German clinical trial management system market, by end user 2013E (% share) 63
FIG. 23 The French clinical trial management system market, by mode of delivery 2013E (%
share) 65
FIG. 24 The French clinical trial management system market, by end user 2013E (% share) 66
FIG. 25 Poland clinical trial management system market, by mode of delivery 2013E (% share)
68
FIG. 26 Poland clinical trial management system market, by end user 2013E (% share) 69
FIG. 27 The Asian clinical trial management system market, by country 2013E (% share) 72
FIG. 28 The Asian clinical trial management system market, by mode of delivery 2013E (%
share) 73
FIG. 29 The Asian clinical trial management system market, by end user 2013E(% share) 75
FIG. 30 The Asian clinical trial management system market, by type 2013E (% share) 76
FIG. 31 The Asian clinical trial management system market, by component 2013E (% share) 78
FIG. 32 The South Korean clinical trial management system market, by mode of delivery 2013E
(% share) 80
FIG. 33 The South Korean clinical trial management system market, by end user 2013E (%
share) 81
22

FIG. 34 The Chinese clinical trial management system market, by mode of delivery 2013E (%
share) 83
FIG. 35 The Chinese clinical trial management system market, by end user 2013E (% share) 84
FIG. 36 Competitive landscape of the global CTMS market 87
FIG. 37 Oracle Corporation total revenue and net income 2011-2013 (USD Million) 90
FIG. 38 Merge Healthcare net sales and net income 2011-2013 (USD Million) 93
FIG. 39 Medidata Solutions total revenue and net income 2011-2013 (USD Million) 96
FIG. 40 PAREXEL International Corporation total service revenue and net income 2011-2013
(USD Million) 99
FIG. 41 BioClinica total revenue and net income 2010-2012 (USD Million) 101
About Us:
Persistence Market Research is a global market research firm specializing- syndicated research,
custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business. As a fullservice market research firm, we stand committed to bringing more accuracy and speed to your business
decisions. From ready-to-purchase market research reports to customized global research solutions, our
engagement models are highly flexible without compromising on our deep-seated research values. Briefly
stated, our mission is to give you access to forecasts and trends analyses that put you on the path to
profitability.
PMRs Services Go Beyond Gleaning Data
23

Most enterprises believe that IT and databases are enough to make an accurate decision. While we do
not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar
decision? We strive to deliver both even with demanding deadlines.
Contact Us:
Addie Thomes
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
24

Persistence Market Research

Enviado por

Dados do documento

Descrição original:

Título original

Direitos autorais

Formatos disponíveis

Compartilhar este documento

Compartilhar ou incorporar documento

Opções de compartilhamento

Você considera este documento útil?

Este conteúdo é inapropriado?

Direitos autorais:

Formatos disponíveis

Persistence Market Research

Enviado por

Direitos autorais:

Formatos disponíveis

Beauty Devices Market - Global Study on Clinical Trial Management

System - Asia to Witness Highest Growth by 2019